Clinical Trials Logo

Cocaine Abuse clinical trials

View clinical trials related to Cocaine Abuse.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00218049 Terminated - Clinical trials for Cocaine-Related Disorders

Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals

Start date: December 2004
Phase: Phase 1
Study type: Interventional

Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to determine the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals.

NCT ID: NCT00218036 Terminated - Opiate Dependence Clinical Trials

Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

Start date: July 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine two medications, modafinil and citalopram, in the treatment of cocaine dependent individuals who are maintained on methadone.

NCT ID: NCT00142883 Terminated - Clinical trials for Cocaine-Related Disorders

The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3

Start date: September 2004
Phase: N/A
Study type: Interventional

Gamma-aminobutyric acid (GABA) is a type of neurotransmitter, which is a chemical that transmits information within and from the brain to all parts of the body. By lowering the level of another neurotransmitter called dopamine, GABA may have the ability to diminish cocaine cravings in addicts. The purpose of this study is to gather information on the interaction between cocaine and selected GABA enhancing medications in individuals addicted to cocaine. This may lead to future clinical studies using GABA medications to treat cocaine addiction.